Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Evaluating non-invasive neurostimulation for frozen shoulder treatment

Official title: Prise En Charge Des Atteintes Proprioceptives Chez Une Population Avec Capsulite Rétractile

Run by Université du Québec à Chicoutimi · NCT06795932 · Data updated 2026-11-12

This study is testing if a new non-invasive treatment using brain stimulation and tendon vibration can help people with frozen shoulder feel better compared to a placebo.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorUniversité du Québec à Chicoutimi
Academic / other
Locations1 site (Saguenay, Quebec)
StatusRecruiting
StartedOctober 17, 2024
Main results expectedApril 2027
Study endsApril 2027
Registry record updatedJanuary 28, 2025
Trial IDNCT06795932 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and over who have been diagnosed with adhesive capsulitis.

Probably not a fit

Patients with cognitive disorders, neurological diseases affecting the upper limbs, or a history of shoulder surgery may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to assess the effectiveness of non-invasive neurostimulation devices, specifically transcranial magnetic stimulation (TMS) and tendon vibration, in treating adhesive capsulitis, commonly known as frozen shoulder. Participants will be divided into two groups: one receiving the actual intervention combined with standardized exercises, and the other receiving a placebo intervention. The study will compare the somatosensory processing and corticospinal excitability between individuals with adhesive capsulitis and healthy controls, with the goal of establishing a better understanding of the condition and its treatment. The trial seeks to provide empirical evidence on the neurophysiological effects of these interventions.

Why it matters

Potential benefit: If successful, this study could lead to improved treatment options for patients suffering from adhesive capsulitis, enhancing their recovery and quality of life.

How similar studies have gone: While the use of neurostimulation in treating adhesive capsulitis is relatively novel, similar approaches in other conditions have shown promising results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18 years old and over
* Good general health
* Adhesive capsulitis (experimental group) or
* No shoulder pain (placebo group)

Exclusion Criteria:

* Cognitive disorders;
* Any neurological disease/injury affecting the upper limbs;
* History or diagnosis of muscle, tendon, or capsular tear;
* Shoulder surgery/prosthesis;
* Pregnant woman;
* Presence of metal in the skull or jaw;
* History of epilepsy.

Where it's running

  • Lab BioNR - UQAC
    Saguenay, Quebec, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.